Cardiol Therapeutics Inc.

Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.

CRDL | NDAQ

Overview

Corporate Details

ISIN(s):: CA14161Y2006
LEI:
Country:: United States of America
Address:: 602-2265 UPPER MIDDLE ROAD EAST, OAKVILLE
Website:: https://www.cardiolrx.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Cardiol Therapeutics Inc. is a clinical-stage life sciences company focused on the research and clinical development of novel anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The company develops treatments for underserved cardiovascular conditions, with a primary focus on pericarditis, myocarditis, and heart failure. Its lead product candidate, CardiolRx™, is an orally administered cannabidiol solution designed to target the underlying mechanisms of inflammation and fibrosis in cardiac disease. The company's pipeline also includes preclinical candidates. Cardiol Therapeutics collaborates with international research centers and clinical experts to advance its therapeutic programs for patients with debilitating heart conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cardiol Therapeutics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cardiol Therapeutics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Cardiol Therapeutics Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
MegaPro Biomedical Co. Ltd. Developing nanomedicines and drug delivery systems for oncology, hematology, and diagnostics.	Malaysia	N/A
Meiho Holdings,Inc. A holding company driving regional growth by supporting construction, HR, and nursing care businesses.	Japan	7369
Mendus Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.	Sweden	IMMU
Metavista3D, Inc. Develops AI-driven, glasses-free 3D holographic displays for the defense sector.	United States of America	M3D
MicroAd,Inc. Data-driven marketing tech providing DSP and SSP solutions for digital advertising.	Japan	9553
Microwave Chemical Co., Ltd. Innovating chemical and metal processing with an eco-friendly microwave platform.	Japan	9227
MindWalk Holdings Corp. AI-powered biotherapeutics firm offering end-to-end antibody discovery and engineering services.	United States of America	HYFT
Minerva Neurosciences, Inc. A clinical-stage biopharma developing treatments for central nervous system (CNS) diseases.	United States of America	NERV
Mitsubishi Research Institute, Inc. A think tank providing research, consulting, and ICT solutions to public & private sectors.	Japan	3636
Modalis Therapeutics Corporation Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.	Japan	4883